CLINICAL_TRIALS
trial_result
· 2012-12-24
Clinical Trial Update: A Long Term Safety Study of Degarelix in Patients With Prostate Cancer [Phase 3]
Summary
A Phase 3 long-term safety study of degarelix in patients with prostate cancer has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ferring Pharmaceuticals | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2012-12-24